skip to content
An introduction to clinical pharmaceutics Preview this item
ClosePreview this item
Checking...

An introduction to clinical pharmaceutics

Author: A T Florence
Publisher: London ; Chicago : Pharmaceutical Press, 2010.
Edition/Format:   Print book : EnglishView all editions and formats
Database:WorldCat
Summary:
This textbook describes a variety of dosage forms and their clinical importance and use. The use and behaviour of dosage forms in different age groups and patient groups will also be considered along with recent developments such as personalised therapies and genomics. It contains relevant examples and clinical case studies.
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Genre/Form: Case studies
Document Type: Book
All Authors / Contributors: A T Florence
ISBN: 9780853696919 0853696918 085369964X 9780853699644
OCLC Number: 141385140
Description: xiii, 179 pages : illustrations ; 24 cm
Contents: 1 What is clinical pharmaceutics? ; Introduction ; Physical concepts ; The nature of the dosage form and outcomes ; Quality of effect ; Ingredients in dosage forms and their influence on outcomes ; Conclusion ; References --
2 Excipients: Not always inert. Introduction ; Usually but not always inert ; E-numbers ; Cross-reactivity ; Dyes used in lymph node identification ; Non-ionic surfactants ; Polyoxyethylene glycols (PEGs) ; Adjuvants as therapeutic substances ; Talc as therapeutic agent and excipient ; Active excipients in multiple therapies ; Conclusions ; References --
3 Thinking chemically. Introduction ; The chemistry of drugs and clinical pharmaceutics ; Chemical nomenclature ; Surface-active drugs ; Acids and bases ; Structural similarities between drugs ; Cross-reactivity ; Beta-lactam antibiotics and the formation of oligomers ; The bisphosphonates ; Hydrophobic and hydrophilic statins ; Photochemical reactions and photoinduced reactions ; Chelation and tetracyclines ; Sugammedex: a cyclodextrin derivative ; Conclusions ; References --
4 Looking at formulations. Introduction ; Protein drugs and formulations ; Monoclonal antibodies (MAbs) ; Amphotericin B formulations ; A doxorubicin formulation: Doxil ; A propofol formulation: Diprivan ; Long-acting depot injections ; Raft-producing oral formulations ; Etoposide (Vepesid, VP 16 and etoposide phosphate) ; Paclitaxel ; Eutectic mixtures of local anaesthetics ; Ciclosporin (cyclosporin) ; Lupron Depot; Prostap SR and Prostap 3 ; Zoladex ; Fluoroquinolone eye drops ; Ionsys: lontophoretic transdermal device for fentanyl ; Parenterals ; Chloramphenicol ; Materials used in drug delivery ; Conclusions ; References --
5 Adverse events and formulations and devices. Introduction ; Dosage form type ; Reactions to impurities ; Abnormal bioavailability, high or low ; Testing for adverse effects ; Nanosystems ; Conclusions ; References --
6 Paediatric, geriatric and special formulations. Introduction ; Extemporaneous formulations ; Effect of formulation and presentation: a case from the literature ; Extemporaneous formulations and performance ; The elderly and their medication ; Enteral feeding ; Drug interactions with nutrient formulations ; Conclusions ; References --
7 Generic medicines: Conventional drugs and biologicals. Introduction ; Regulatory statements on generic products ; Generics: A question of quality ; Specific conditions and generics ; Reading and deconstructing the literature on bioequivalence ; Antiretroviral drugs ; Bioequivalence of ophthalmic products ; The case of sevoflurane ; Generic biologicals (biologics) ; Conclusions ; References --
8 The future: Delivery systems for modem therapeutics ; Introduction ; Personalised medicine and medicines ; Drug delivery and personalised medicines ; Technologies ; Nanotechnoiogy ; Cell-based therapies ; Gene therapy ; Conclusions ; References.
Responsibility: Alexander T. Florence.

Abstract:

Considers the importance of pharmaceutics and pharmaceutical dosage form design by considering the clinical use of modern drugs. This book also considers the use and behaviour of dosage forms in  Read more...

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


Primary Entity

<http://www.worldcat.org/oclc/141385140> # An introduction to clinical pharmaceutics
    a schema:Book, schema:CreativeWork ;
   library:oclcnum "141385140" ;
   library:placeOfPublication <http://id.loc.gov/vocabulary/countries/enk> ;
   library:placeOfPublication <http://dbpedia.org/resource/London> ; # London
   library:placeOfPublication <http://dbpedia.org/resource/Chicago> ; # Chicago
   schema:about <http://id.loc.gov/authorities/subjects/sh85039727> ; # Drugs--Dosage forms
   schema:about <http://experiment.worldcat.org/entity/work/data/316664788#Topic/dosage_forms> ; # Dosage Forms
   schema:about <http://experiment.worldcat.org/entity/work/data/316664788#Topic/drug_compounding> ; # Drug Compounding
   schema:about <http://dewey.info/class/615.19/e22/> ;
   schema:about <http://id.worldcat.org/fast/1060115> ; # Pharmaceutical chemistry
   schema:about <http://id.worldcat.org/fast/898801> ; # Drugs--Dosage forms
   schema:about <http://experiment.worldcat.org/entity/work/data/316664788#Topic/chemistry_pharmaceutical> ; # Chemistry, Pharmaceutical
   schema:about <http://experiment.worldcat.org/entity/work/data/316664788#Topic/technology_pharmaceutical> ; # Technology, Pharmaceutical
   schema:bookFormat bgn:PrintBook ;
   schema:creator <http://viaf.org/viaf/54234770> ; # Alexander Taylor Florence
   schema:datePublished "2010" ;
   schema:description "This textbook describes a variety of dosage forms and their clinical importance and use. The use and behaviour of dosage forms in different age groups and patient groups will also be considered along with recent developments such as personalised therapies and genomics. It contains relevant examples and clinical case studies."@en ;
   schema:description "1 What is clinical pharmaceutics? ; Introduction ; Physical concepts ; The nature of the dosage form and outcomes ; Quality of effect ; Ingredients in dosage forms and their influence on outcomes ; Conclusion ; References -- 2 Excipients: Not always inert. Introduction ; Usually but not always inert ; E-numbers ; Cross-reactivity ; Dyes used in lymph node identification ; Non-ionic surfactants ; Polyoxyethylene glycols (PEGs) ; Adjuvants as therapeutic substances ; Talc as therapeutic agent and excipient ; Active excipients in multiple therapies ; Conclusions ; References -- 3 Thinking chemically. Introduction ; The chemistry of drugs and clinical pharmaceutics ; Chemical nomenclature ; Surface-active drugs ; Acids and bases ; Structural similarities between drugs ; Cross-reactivity ; Beta-lactam antibiotics and the formation of oligomers ; The bisphosphonates ; Hydrophobic and hydrophilic statins ; Photochemical reactions and photoinduced reactions ; Chelation and tetracyclines ; Sugammedex: a cyclodextrin derivative ; Conclusions ; References -- 4 Looking at formulations. Introduction ; Protein drugs and formulations ; Monoclonal antibodies (MAbs) ; Amphotericin B formulations ; A doxorubicin formulation: Doxil ; A propofol formulation: Diprivan ; Long-acting depot injections ; Raft-producing oral formulations ; Etoposide (Vepesid, VP 16 and etoposide phosphate) ; Paclitaxel ; Eutectic mixtures of local anaesthetics ; Ciclosporin (cyclosporin) ; Lupron Depot; Prostap SR and Prostap 3 ; Zoladex ; Fluoroquinolone eye drops ; Ionsys: lontophoretic transdermal device for fentanyl ; Parenterals ; Chloramphenicol ; Materials used in drug delivery ; Conclusions ; References -- 5 Adverse events and formulations and devices. Introduction ; Dosage form type ; Reactions to impurities ; Abnormal bioavailability, high or low ; Testing for adverse effects ; Nanosystems ; Conclusions ; References -- 6 Paediatric, geriatric and special formulations. Introduction ; Extemporaneous formulations ; Effect of formulation and presentation: a case from the literature ; Extemporaneous formulations and performance ; The elderly and their medication ; Enteral feeding ; Drug interactions with nutrient formulations ; Conclusions ; References -- 7 Generic medicines: Conventional drugs and biologicals. Introduction ; Regulatory statements on generic products ; Generics: A question of quality ; Specific conditions and generics ; Reading and deconstructing the literature on bioequivalence ; Antiretroviral drugs ; Bioequivalence of ophthalmic products ; The case of sevoflurane ; Generic biologicals (biologics) ; Conclusions ; References -- 8 The future: Delivery systems for modem therapeutics ; Introduction ; Personalised medicine and medicines ; Drug delivery and personalised medicines ; Technologies ; Nanotechnoiogy ; Cell-based therapies ; Gene therapy ; Conclusions ; References."@en ;
   schema:exampleOfWork <http://worldcat.org/entity/work/id/316664788> ;
   schema:genre "Case studies"@en ;
   schema:inLanguage "en" ;
   schema:name "An introduction to clinical pharmaceutics"@en ;
   schema:productID "141385140" ;
   schema:publication <http://www.worldcat.org/title/-/oclc/141385140#PublicationEvent/london_chicago_pharmaceutical_press_2010> ;
   schema:publisher <http://experiment.worldcat.org/entity/work/data/316664788#Agent/pharmaceutical_press> ; # Pharmaceutical Press
   schema:workExample <http://worldcat.org/isbn/9780853699644> ;
   schema:workExample <http://worldcat.org/isbn/9780853696919> ;
   wdrs:describedby <http://www.worldcat.org/title/-/oclc/141385140> ;
    .


Related Entities

<http://dbpedia.org/resource/Chicago> # Chicago
    a schema:Place ;
   schema:name "Chicago" ;
    .

<http://dbpedia.org/resource/London> # London
    a schema:Place ;
   schema:name "London" ;
    .

<http://experiment.worldcat.org/entity/work/data/316664788#Agent/pharmaceutical_press> # Pharmaceutical Press
    a bgn:Agent ;
   schema:name "Pharmaceutical Press" ;
    .

<http://experiment.worldcat.org/entity/work/data/316664788#Topic/chemistry_pharmaceutical> # Chemistry, Pharmaceutical
    a schema:Intangible ;
   schema:name "Chemistry, Pharmaceutical"@en ;
    .

<http://experiment.worldcat.org/entity/work/data/316664788#Topic/technology_pharmaceutical> # Technology, Pharmaceutical
    a schema:Intangible ;
   schema:name "Technology, Pharmaceutical"@en ;
    .

<http://id.loc.gov/authorities/subjects/sh85039727> # Drugs--Dosage forms
    a schema:Intangible ;
   schema:name "Drugs--Dosage forms"@en ;
    .

<http://id.worldcat.org/fast/1060115> # Pharmaceutical chemistry
    a schema:Intangible ;
   schema:name "Pharmaceutical chemistry"@en ;
    .

<http://id.worldcat.org/fast/898801> # Drugs--Dosage forms
    a schema:Intangible ;
   schema:name "Drugs--Dosage forms"@en ;
    .

<http://viaf.org/viaf/54234770> # Alexander Taylor Florence
    a schema:Person ;
   schema:familyName "Florence" ;
   schema:givenName "Alexander Taylor" ;
   schema:givenName "A. T." ;
   schema:name "Alexander Taylor Florence" ;
    .

<http://worldcat.org/isbn/9780853696919>
    a schema:ProductModel ;
   schema:isbn "0853696918" ;
   schema:isbn "9780853696919" ;
    .

<http://worldcat.org/isbn/9780853699644>
    a schema:ProductModel ;
   schema:isbn "085369964X" ;
   schema:isbn "9780853699644" ;
    .


Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.